KMT2A and neuroblastoma: The library was screened against an infant MLL-AF4 leukemia cell line (PER-485) in parallel with a human neuroblastoma cell line (BE(2)-C) as representative of a MLL-wt pediatric tumour, using Alamar Blue viability assays at a single dose of 10 μM for each compound.